"Community members have more impact on their neighbors than celebrities": leveraging community partnerships to build COVID-19 vaccine confidence.
COVID-19
Community engagement
Public health messaging
Vaccine confidence
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
16 02 2023
16 02 2023
Historique:
received:
27
05
2022
accepted:
02
02
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
22
2
2023
Statut:
epublish
Résumé
Vaccines are a strong public health tool to protect against severe disease, hospitalization, and death from COVID-19. Still, inequities in COVID-19 vaccination rates and health outcomes continue to exist among Black and Latino populations. Boston Medical Center (BMC) has played a significant role in vaccinating medically underserved populations, and organized a series of community-engaged conversations to better understand community concerns regarding the COVID-19 vaccine. This paper describes the themes which resulted from these community-engaged conversations and proposes next steps for healthcare leaders. We accessed nine publicly available recordings of the community-engaged conversations which were held between March 2021 and September 2021 and ranged from 8 to 122 attendees. Six conversations prioritized specific groups: the Haitian-Creole community, the Cape Verdean community, the Latino community, the Black Christian Faith community, guardians who care for children living with disabilities, and individuals affected by systemic lupus erythematosus. Remaining conversations targeted the general public of the Greater Boston Area. We employed a Consolidated Framework for Implementation Research-driven codebook to code our data. Our analysis utilized a modified version of qualitative rapid analysis methods. Five main themes emerged from these community-engaged conversations: (1) Structural factors are important barriers to COVID-19 vaccination; (2) Mistrust exists due to the negative impact of systemic oppression and perceived motivation of the government; (3) There is a desire to learn more about biological and clinical characteristics of the COVID-19 vaccine as well as the practical implications of being vaccinated; (4) Community leaders emphasize community engagement for delivering COVID-19 information and education and; (5) Community leaders believe that the COVID-19 vaccine is a solution to address the pandemic. This study illustrates a need for community-engaged COVID-19 vaccine messaging which reflects the nuances of the COVID-19 vaccine and pandemic without oversimplifying information. In highlighting common concerns of the Greater Boston Area which contribute to a lack of confidence in the COVID-19 vaccine, we underscore important considerations for public health and healthcare leadership in the development of initiatives which work to advance health equity.
Sections du résumé
BACKGROUND
Vaccines are a strong public health tool to protect against severe disease, hospitalization, and death from COVID-19. Still, inequities in COVID-19 vaccination rates and health outcomes continue to exist among Black and Latino populations. Boston Medical Center (BMC) has played a significant role in vaccinating medically underserved populations, and organized a series of community-engaged conversations to better understand community concerns regarding the COVID-19 vaccine. This paper describes the themes which resulted from these community-engaged conversations and proposes next steps for healthcare leaders.
METHODS
We accessed nine publicly available recordings of the community-engaged conversations which were held between March 2021 and September 2021 and ranged from 8 to 122 attendees. Six conversations prioritized specific groups: the Haitian-Creole community, the Cape Verdean community, the Latino community, the Black Christian Faith community, guardians who care for children living with disabilities, and individuals affected by systemic lupus erythematosus. Remaining conversations targeted the general public of the Greater Boston Area. We employed a Consolidated Framework for Implementation Research-driven codebook to code our data. Our analysis utilized a modified version of qualitative rapid analysis methods.
RESULTS
Five main themes emerged from these community-engaged conversations: (1) Structural factors are important barriers to COVID-19 vaccination; (2) Mistrust exists due to the negative impact of systemic oppression and perceived motivation of the government; (3) There is a desire to learn more about biological and clinical characteristics of the COVID-19 vaccine as well as the practical implications of being vaccinated; (4) Community leaders emphasize community engagement for delivering COVID-19 information and education and; (5) Community leaders believe that the COVID-19 vaccine is a solution to address the pandemic.
CONCLUSION
This study illustrates a need for community-engaged COVID-19 vaccine messaging which reflects the nuances of the COVID-19 vaccine and pandemic without oversimplifying information. In highlighting common concerns of the Greater Boston Area which contribute to a lack of confidence in the COVID-19 vaccine, we underscore important considerations for public health and healthcare leadership in the development of initiatives which work to advance health equity.
Identifiants
pubmed: 36797724
doi: 10.1186/s12889-023-15198-6
pii: 10.1186/s12889-023-15198-6
pmc: PMC9933023
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
350Subventions
Organisme : NIH HHS
ID : 1OT2HL156812-01
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
BMJ Open. 2018 Oct 8;8(10):e019993
pubmed: 30297341
Glob Health Action. 2015 Dec 18;8:29842
pubmed: 26689460
J Urban Health. 2022 Feb;99(1):3-14
pubmed: 34940933
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):864-869
pubmed: 32644981
CA Cancer J Clin. 2020 Jan;70(1):31-46
pubmed: 31661164
J Racial Ethn Health Disparities. 2022 Oct;9(5):1697-1725
pubmed: 34462902
Implement Sci. 2019 Feb 1;14(1):11
pubmed: 30709368
N Engl J Med. 2021 Feb 4;384(5):e12
pubmed: 33471971
Int J Environ Res Public Health. 2021 Sep 20;18(18):
pubmed: 34574827
Open Forum Infect Dis. 2022 Mar 10;9(5):ofac124
pubmed: 35493113
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
J Racial Ethn Health Disparities. 2022 Feb;9(1):236-246
pubmed: 33469868
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
N Engl J Med. 2020 Dec 31;383(27):2593-2595
pubmed: 33369352
Soc Sci Med. 2010 Oct;71(8):1390-8
pubmed: 20822840
N Engl J Med. 2021 Apr 22;384(16):1483-1487
pubmed: 33657291
Psychol Trauma. 2020 Jul;12(5):443-445
pubmed: 32478545
J Racial Ethn Health Disparities. 2022 Dec;9(6):2361-2374
pubmed: 34713336
Euro Surveill. 2021 Jul;26(28):
pubmed: 34269175
Hastings Cent Rep. 1978 Dec;8(6):21-9
pubmed: 721302
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Ann Intern Med. 2022 Jun;175(6):879-884
pubmed: 35576586
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Hum Vaccin Immunother. 2019;15(7-8):1615-1627
pubmed: 30633623
JAMA Netw Open. 2021 Sep 1;4(9):e2127582
pubmed: 34591103
N Engl J Med. 2021 Nov 4;385(19):1761-1773
pubmed: 34525277
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4296-301
pubmed: 27044069
Milbank Q. 2018 Dec;96(4):635-671
pubmed: 30350420
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):431-436
pubmed: 33764963
N Engl J Med. 2021 Dec 16;385(25):e90
pubmed: 34551224
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
JAMA Netw Open. 2021 Oct 1;4(10):e2128575
pubmed: 34643719